The plasma leptin/adiponectin ratio predicts first cardiovascular event in men: A prospective nested case–control study

European Journal of Internal Medicine - Tập 23 - Trang 755-759 - 2012
Paul J.W.H. Kappelle1, Robin P.F. Dullaart1, André P. van Beek1, Hans L. Hillege2, Bruce H.R. Wolffenbuttel1
1Department of Endocrinology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands
2Department of Cardiology, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands

Tài liệu tham khảo

Matsusawa, 2004, Adiponectin and metabolic syndrome, Arterioscler Thromb Vasc Biol, 24, 29, 10.1161/01.ATV.0000099786.99623.EF Yu, 2005, Adipocyte signaling and lipid homeostasis: sequelae of insulin-resistant adipose tissue, Circ Res, 96, 1042, 10.1161/01.RES.0000165803.47776.38 Beltowski, 2006, Leptin and atherosclerosis, Atherosclerosis, 189, 47, 10.1016/j.atherosclerosis.2006.03.003 Ronti, 2006, The endocrine function of adipose tissue: an update, Clin Endocrinol (Oxf), 64, 355 Dallinga-Thie, 2010, Do genome-wide association scans provide additional information on the variation of plasma adiponectin concentrations?, Atherosclerosis, 208, 328, 10.1016/j.atherosclerosis.2009.12.014 Sattar, 2009, Leptin and coronary heart disease: prospective study and systematic review, J Am Coll Cardiol, 53, 167, 10.1016/j.jacc.2008.09.035 Sattar, 2006, Adiponectin and coronary heart disease: a prospective study and meta-analysis, Circulation, 114, 623, 10.1161/CIRCULATIONAHA.106.618918 Ku, 2011, Association of low leptin with cardiovascular events and mortality in patients with stable coronary artery disease: The Heart and Soul Study, Atherosclerosis, 217, 503, 10.1016/j.atherosclerosis.2010.10.047 Dekker, 2008, Prognostic value of adiponectin for cardiovascular disease and mortality, J Clin Endocrinol Metab, 93, 1489, 10.1210/jc.2007-1436 Satoh, 2004, Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients, Diabetes Care, 27, 2488, 10.2337/diacare.27.10.2488 Kotani, 2005, Leptin:adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima–media thickness, Diabetologia, 48, 2684, 10.1007/s00125-005-0015-4 Norata, 2007, Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery, Stroke, 38, 2844, 10.1161/STROKEAHA.107.485540 Takamura, 2010, Leptin to high-molecular-weight adiponectin ratio is independently correlated with carotid intima–media thickness in men, but not in women, Biomarkers, 15, 340, 10.3109/13547501003735532 Dullaart, 2010, Carotid intima media thickness is associated with plasma adiponectin but not with the leptin:adiponectin ratio independently of metabolic syndrome, Atherosclerosis, 211, 393, 10.1016/j.atherosclerosis.2010.03.024 Bevan, 2011, Adiponectin level as a consequence of genetic variation, but not leptin level or leptin:adiponectin ratio, is a risk factor for carotid intima–media thickness, Stroke, 42, 1510, 10.1161/STROKEAHA.110.602375 Karakas, 2010, Leptin, adiponectin, their ratio and risk of coronary heart disease: results from the MONICA/KORA Augsburg Study 1984–2002, Atherosclerosis, 209, 220, 10.1016/j.atherosclerosis.2009.08.020 Shetty, 2004, Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes, Diabetes Care, 27, 2450, 10.2337/diacare.27.10.2450 Ble, 2005, Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study), Am J Cardiol, 96, 991, 10.1016/j.amjcard.2005.05.058 Dullaart, 2009, High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus, Clin Endocrinol (Oxf), 70, 221, 10.1111/j.1365-2265.2008.03306.x Finucane, 2009, Correlation of the leptin:adiponectin ratio with measures of insulin resistance in non-diabetic individuals, Diabetologia, 52, 2345, 10.1007/s00125-009-1508-3 Borggreve, 2007, High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides, Eur Heart J, 28, 1012, 10.1093/eurheartj/ehm062 Miettinen, 1985, Design of sampling from the base, 69 Kappelle, 2011, Apolipoprotein B/A-I and total cholesterol/high-density lipoprotein cholesterol ratios both predict cardiovascular events in the general population independently of nonlipid risk factors, albuminuria and C-reactive protein, J Intern Med, 269, 232, 10.1111/j.1365-2796.2010.02323.x Dullaart, 2007, Lower plasma adiponectin is a marker of increased intima–media thickness associated with type 2 diabetes mellitus and with male gender, Eur J Endocrinol, 156, 387, 10.1530/EJE-06-0681 Lambers Heerspink, 2008, Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality, Am J Epidemiol, 168, 897, 10.1093/aje/kwn209 Rathmann, 2007, Adiponectin and cardiovascular mortality: evidence for “reverse epidemiology”, Horm Metab Res, 39, 1, 10.1055/s-2007-958630 Vergès, 2006, Adiponectin is an important determinant of apoA-I catabolism, Arterioscler Thromb Vasc Biol, 26, 1364, 10.1161/01.ATV.0000219611.50066.bd Chan, 2005, Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism, Clin Chem, 51, 578, 10.1373/clinchem.2004.045120 Diercks, 2000, Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study, Eur Heart J, 21, 1922, 10.1053/euhj.2000.2248 Stehouwer, 2006, Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms, J Am Soc Nephrol, 17, 2106, 10.1681/ASN.2005121288 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619 van der Steeg, 2007, Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: a case–control analysis in EPIC-Norfolk, Ann Intern Med, 146, 640, 10.7326/0003-4819-146-9-200705010-00007 McQueen, 2008, Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case–control study, Lancet, 372, 224, 10.1016/S0140-6736(08)61076-4